title: 57th American Society of Hematology Annual Meeting.
authors.forename: Lan-Lan
authors.initials: LL
authors.lastname: Smith
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D064096:Aurora Kinase A / Q000037:antagonists & inhibitors; D001381:Azepines / Q000627:therapeutic use; D002678:Chimera; D016044:Fusion Proteins, bcr-abl / Q000037:antagonists & inhibitors; D006405:Hematology; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics; D016411:Lymphoma, T-Cell, Peripheral / Q000188:drug therapy; D009101:Multiple Myeloma / Q000188:drug therapy / Q000628:therapy*; D011743:Pyrimidines / Q000627:therapeutic use; D012955:Societies, Medical; D019311:Staurosporine / Q000031:analogs & derivatives / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000637:transplantation; D014481:United States; D051941:fms-Like Tyrosine Kinase 3 / Q000235:genetics
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D001381:Azepines; C550258:MLN 8237; D011743:Pyrimidines; C556306:daratumumab; C497970:FLT3 protein, human; D051941:fms-Like Tyrosine Kinase 3; D016044:Fusion Proteins, bcr-abl; D064096:Aurora Kinase A; D019311:Staurosporine; C059539:midostaurin